Adirondack Trust Co. reduced its position in SPDR S&P Biotech (NYSEARCA:XBI) by 67.9% during the second quarter, Holdings Channel reports. The fund owned 1,895 shares of the exchange traded fund’s stock after selling 4,000 shares during the period. Adirondack Trust Co.’s holdings in SPDR S&P Biotech were worth $146,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently modified their holdings of XBI. National Planning Corp purchased a new position in shares of SPDR S&P Biotech during the second quarter worth about $211,000. Boston Advisors LLC purchased a new position in shares of SPDR S&P Biotech during the second quarter worth about $213,000. Telemus Capital LLC purchased a new position in shares of SPDR S&P Biotech during the second quarter worth about $232,000. FineMark National Bank & Trust increased its position in shares of SPDR S&P Biotech by 7.4% in the second quarter. FineMark National Bank & Trust now owns 5,210 shares of the exchange traded fund’s stock worth $402,000 after buying an additional 360 shares during the last quarter. Finally, Meridian Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech during the second quarter worth about $432,000.

SPDR S&P Biotech (NYSEARCA:XBI) opened at 74.47 on Friday. The stock has a 50 day moving average of $78.58 and a 200-day moving average of $71.46. SPDR S&P Biotech has a 12 month low of $53.15 and a 12 month high of $82.38.

ILLEGAL ACTIVITY WARNING: “Adirondack Trust Co. Has $146,000 Stake in SPDR S&P Biotech (NYSEARCA:XBI)” was first posted by Daily Political and is the property of of Daily Political. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/11/adirondack-trust-co-has-146000-stake-in-spdr-sp-biotech-nysearcaxbi.html.

SPDR S&P Biotech Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech (NYSEARCA:XBI).

Institutional Ownership by Quarter for SPDR S&P Biotech (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech and related companies with MarketBeat.com's FREE daily email newsletter.